📖

enteric-nervous-system-expanded

wiki page Created: 2026-04-02T20:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-cell-types-enteric-nervous-system-e
Related Entities
cell-types-enteric-nervous-system-expanded
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

📊 Evidence Profile
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
311
Outgoing
499
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Linked Artifacts (518)
mentions🧪Lipid Droplet Dynamics as Phenotype Switches70%
mentions🧪Mechanosensitive Ion Channel Reprogramming70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
mentions🧪Purinergic Signaling Polarization Control70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧪Lipid Droplet Dynamics as Phenotype Switches63%
related🧪Mechanosensitive Ion Channel Reprogramming63%
related🧪Purinergic Signaling Polarization Control63%
related🧪Complement C1q Subtype Switching55%
related🧪Chromatin Accessibility Restoration via BRD4 Modulation55%
related🧪Mitochondrial Transfer Pathway Enhancement55%
related🧪Nutrient-Sensing Epigenetic Circuit Reactivation55%
related🧪Circadian Rhythm Entrainment of Reactive Astrocytes55%
related🧪PARP1 Inhibition Therapy55%
related🧪Chaperone-Mediated APOE4 Refolding Enhancement55%
related🧪Ganglioside Rebalancing Therapy55%
related🧪Programmable Neuronal Circuit Repair via Epigenetic CRISPR55%
related🧪Autophagosome Maturation Checkpoint Control55%
related🧪Aquaporin-4 Polarization Rescue55%
related🧪Enteric Nervous System Prion-Like Propagation Blockade55%
related🧪TREM2-Mediated Selective Aggregate Clearance Pathway55%
related🧪APOE-Mediated Synaptic Lipid Raft Stabilization55%
related🧪Magnetosonic-Triggered Transferrin Receptor Clustering55%
related🧪Vocal Cord Neuroplasticity Stimulation55%
related🧪APOE Isoform Expression Across Glial Subtypes55%
related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi55%
related🧪Synthetic Biology Rewiring via Orthogonal Receptors55%
related🧪Synaptic Vesicle Tau Capture Inhibition55%
related🧪Quantum Coherence Disruption in Cellular Communication55%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation55%
related🧪Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro55%
related🧪Orexin-Microglia Modulation Therapy55%
related🧪VCP-Mediated Autophagy Enhancement55%
related🧪Pharmacological Enhancement of APOE4 Glycosylation55%
related🧪Heat Shock Protein 70 Disaggregase Amplification55%
related🧪Prefrontal sensory gating circuit restoration via PV interne55%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer55%
related🧪KDM6A-Mediated H3K27me3 Rejuvenation55%
related🧪RAB27A-dependent extracellular vesicle engineering for mitoc55%
related🧪Purinergic P2Y12 Inverse Agonist Therapy55%
related🧪Context-Dependent CRISPR Activation in Specific Neuronal Sub55%
related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem55%
related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto55%
related🧪Adenosine-Astrocyte Metabolic Reset55%
related🧪Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy55%
related🧪Competitive APOE4 Domain Stabilization Peptides55%
related🧪Near-infrared light therapy stimulates COX4-dependent mitoch55%
related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition55%
related🧪Mitochondrial RNA Granule Rescue Pathway55%
related🧪Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci55%
related🧪Microbial Inflammasome Priming Prevention55%
related🧪Low Complexity Domain Cross-Linking Inhibition55%
related🧪CYP46A1 Overexpression Gene Therapy55%
related🧪Mitochondrial-Lysosomal Contact Site Engineering55%
related🧪HSP90-Tau Disaggregation Complex Enhancement55%
related🧪Mechanosensitive Ion Channel Reprogramming55%
related🧪Flotillin-1 Stabilization Compounds55%
related🧪Sleep Spindle-Synaptic Plasticity Enhancement55%
related🧪Multi-Modal Stress Response Harmonization55%
related🧪RNA-Binding Competition Therapy for TDP-43 Cross-Seeding55%
related🧪Senescence-Associated Myelin Lipid Remodeling55%
related🧪Digital Twin-Guided Metabolic Reprogramming55%
related🧪Piezoelectric Nanochannel BBB Disruption55%
related🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat55%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th55%
related🧪Restoring Neuroprotective Tryptophan Metabolism via Targeted55%
related🧪Blood-Brain Barrier SPM Shuttle System55%
related🧪Complement-Mediated Synaptic Pruning Dysregulation55%
related🧪Lysosomal Enzyme Trafficking Correction55%
related🧪Trinucleotide Repeat Sequestration via CRISPR-Guided RNA Tar55%
related🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu55%
related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor55%
related🧪The Glial Ketone Metabolic Shunt Hypothesis55%
related🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai55%
related🧪APOE-TREM2 Interaction Modulation55%
related🧪Epigenetic Memory Erasure via TET2 Activation55%
related🧪Targeted APOE4-to-APOE3 Base Editing Therapy55%
related🧪Glial Glycocalyx Remodeling Therapy55%
related🧪The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction55%
related🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism55%
related🧪Age-Dependent Complement C4b Upregulation Drives Synaptic Vu55%
related🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli55%
related🧪Membrane Cholesterol Gradient Modulators55%
related🧪Oligodendrocyte White Matter Vulnerability55%
related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming55%
related🧪GAP43-mediated tunneling nanotube stabilization enhances neu55%
related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)55%
related🧪Reelin-Mediated Cytoskeletal Stabilization Protocol55%
related🧪Extracellular Matrix Stiffness Modulation55%
related🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics55%
related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri55%
related🧪Circadian Clock-Autophagy Synchronization55%
related🧪Correcting Gut Microbial Dopamine Imbalance to Support Syste55%
related🧪Cryptic Exon Silencing Restoration55%
related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue55%
related🧪Nucleolar Stress Response Normalization55%
related🧪Transcriptional Autophagy-Lysosome Coupling55%
related🧪Liquid-Liquid Phase Separation Modifier Therapy55%
related🧪Circadian-Synchronized LRP1 Pathway Activation55%
related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener55%
related🧪HDAC3-Selective Inhibition for Clock Reset55%
related🧪LRP1-Dependent Tau Uptake Disruption55%
related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho55%
related🧪SASP-Mediated Cholinergic Synapse Disruption55%
related🧪TET2-Mediated Demethylation Rejuvenation Therapy55%
related🧪Noradrenergic-Tau Propagation Blockade55%
related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu55%
related🧪SIRT6-NAD+ Axis Enhancement Therapy55%
related🧪Senescent Cell Mitochondrial DNA Release55%
related🧪PINK1/Parkin-Independent Mitophagy Bypass for Enhanced Donor55%
related🧪Gut Barrier Permeability-α-Synuclein Axis Modulation55%
related🧪Proteostasis Enhancement via APOE Chaperone Targeting55%
related🧪Gap Junction Hemichannel Modulation for Controlled Mitochond55%
related🧪Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption55%
related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy55%
related🧪Perforant Path Presynaptic Terminal Protection Strategy55%
related🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection55%
related🧪CX43 hemichannel engineering enables size-selective mitochon55%
related🧪Complement C1QA Spatial Gradient in Cortical Layers55%
related🧪Retinal Vascular Microcirculation Rescue55%
related🧪Multi-Modal CRISPR Platform for Simultaneous Editing and Mon55%
related🧪R-Loop Resolution Enhancement Therapy55%
related🧪Axonal RNA Transport Reconstitution55%
related🧪Glycine-Rich Domain Competitive Inhibition55%
related🧪Cholesterol-CRISPR Convergence Therapy for Neurodegeneration55%
related🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati55%
related🧪Microglia-Derived Extracellular Vesicle Engineering for Targ55%
related🧪Ephrin-B2/EphB4 Axis Manipulation55%
related🧪Optogenetic Control of Mitochondrial Transfer Networks55%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides55%
related🧪Selective HDAC3 Inhibition with Cognitive Enhancement55%
related🧪Extracellular Vesicle Biogenesis Modulation55%
related🧪Metabolic Switch Targeting for A1→A2 Repolarization55%
related🧪DNMT1-Targeting Antisense Oligonucleotide Reset55%
related🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists55%
related🧪Temporal Decoupling via Circadian Clock Reset55%
related🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution55%
related🧪Circadian-Gated Maresin Biosynthesis Amplification55%
related🧪Epigenetic Memory Reprogramming for Alzheimer's Disease55%
related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro55%
related🧪Astrocytic Connexin-43 Upregulation Enhances Neuroprotective55%
related🧪Senescence-Activated NAD+ Depletion Rescue55%
related🧪RNA Granule Nucleation Site Modulation55%
related🧪Targeted Butyrate Supplementation for Microglial Phenotype M55%
related🧪Mitochondrial SPM Synthesis Platform Engineering55%
related🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In55%
related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction55%
related🧪TFEB-PGC1α Mitochondrial-Lysosomal Decoupling55%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination55%
related🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK55%
related🧪Temporal TET2-Mediated Hydroxymethylation Cycling55%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna55%
related🧪Vagal Afferent Microbial Signal Modulation55%
related🧪Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam55%
related🧪SASP-Mediated Complement Cascade Amplification55%
related🧪Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro55%
related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation55%
related🧪APOE Isoform Conversion Therapy55%
related🧪SASP-Driven Aquaporin-4 Dysregulation55%
related🧪Trans-Synaptic Adhesion Molecule Modulation55%
related🧪Glymphatic System-Enhanced Antibody Clearance Reversal55%
related🧪Gamma entrainment therapy to restore hippocampal-cortical sy55%
related🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 55%
related🧪Ocular Immune Privilege Extension55%
related🧪Lysosomal Calcium Channel Modulation Therapy55%
related🧪TFAM overexpression creates mitochondrial donor-recipient gr55%
related🧪Phase-Separated Organelle Targeting55%
related🧪Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A55%
related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m55%
related🧪Sphingolipid Metabolism Reprogramming55%
related🧪Hypocretin-Neurogenesis Coupling Therapy55%
related🧪Netrin-1 Gradient Restoration55%
related🧪Cross-Seeding Prevention Strategy55%
related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors55%
related🧪Circadian-Synchronized Proteostasis Enhancement55%
related🧪Microglial Purinergic Reprogramming55%
related🧪Synthetic Biology Approach: Designer Mitochondrial Export Sy55%
related🧪Biorhythmic Interference via Controlled Sleep Oscillations55%
related🧪Transglutaminase-2 Cross-Linking Inhibition Strategy55%
related🧪GFAP-Positive Reactive Astrocyte Subtype Delineation55%
related🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho55%
related🧪Brain Insulin Resistance with Glucose Transporter Dysfunctio55%
related🧪Smartphone-Detected Motor Variability Correction55%
related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis55%
related🧪HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor55%
related🧪APOE-Dependent Autophagy Restoration55%
related🧪Stress Granule Phase Separation Modulators55%
related🧪Synthetic Biology BBB Endothelial Cell Reprogramming55%
related🧪Complement C1q Mimetic Decoy Therapy55%
related🧪APOE4-Selective Lipid Nanoemulsion Therapy55%
related🧪Arginine Methylation Enhancement Therapy55%
related🧪Lipid Droplet Dynamics as Phenotype Switches55%
related🧪Lysosomal Membrane Repair Enhancement55%
related🧪Purinergic Signaling Polarization Control55%
related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones55%
related🧪Senescence-Induced Lipid Peroxidation Spreading55%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
mentions🧪Enteric Nervous System Prion-Like Propagation Blockade50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
mentions🧪Blood-Brain Barrier SPM Shuttle System50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming50%
mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
mentions🧪Senescent Cell Mitochondrial DNA Release50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
mentions🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem50%
mentions🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
see_also📖Short Chain Fatty Acids in Neurodegeneration45%
see_also📖Investment Landscape: ALS45%
see_also📖Synaptic Biomarkers in Neurodegeneration45%
see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration45%
see_also📖GDNF Signaling Pathway in Neurodegeneration45%
see_also📖Healthcare Economics and Cost of Illness in Progressive Supr45%
see_also📖mTOR Signaling Pathway in Neurodegeneration45%
see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration45%
see_also📖Neuroresilience Mechanisms and Evidence45%
see_also📖ABCA7 Lipid Transport and Microglial Phagocytosis AD Causal 45%
see_also📖Potential Impact Measures — Neurodegeneration45%
see_also📖Callosal Disconnection and Interhemispheric Dysfunction in C45%
see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration45%
see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 45%
see_also📖Imaging Biomarkers for Corticobasal Syndrome and Progressive45%
see_also📖Simultanagnosia and Balint's Syndrome in Corticobasal S45%
see_also📖Sleep Dysfunction in Neurodegeneration45%
see_also📖Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pi45%
see_also📖First-in-Human 4R Tau Ligand Study in PSP (NCT07348276)45%
see_also📖Noradrenergic Signaling Pathway in Neurodegeneration45%
see_also📖HIV-Associated Neurocognitive Disorders (HAND)45%
see_also📖FTDP-17 Clinical Phenotypes and Disease Progression45%
see_also📖Silymarin for Neuroprotection and Symptom Management in Park45%
see_also📖acetylcholine-signaling-neurodegeneration45%
see_also📖Jervell and Lange-Nielsen Syndrome45%
see_also📖IL-6 (Interleukin-6) in Neurodegeneration45%
see_also📖Metal Homeostasis in Neurodegeneration45%
see_also📖VILIP-1 and YKL-40 - Alzheimer's Disease Biomarkers45%
see_also📖Lipid Dysregulation in Neurodegeneration45%
see_also📖Alexander Disease Genetic Variants45%
see_also📖Molecular Chaperones in Neurodegeneration45%
see_also📖ATP13A9 and Parkinson's Disease45%
see_also📖Progesterone Signaling Pathway in Neurodegeneration45%
see_also📖Safety and Clinical Outcomes Study: Amniotic and Umbilical C45%
see_also📖synaptic-vesicle-cycling-neurodegeneration45%
see_also📖Speech Therapy and Communication Aids in Corticobasal Syndro45%
see_also📖DALY Methodology — Neurodegeneration45%
see_also📖Phase 3 Study to Compare the Efficacy and Safety of Masitini45%
see_also📖SNCA Gene Variants and Mutations45%
see_also📖GBA Brain Molecular Imaging and Blood Biomarkers for Precisi45%
see_also📖mTOR Signaling in Neurodegeneration45%
see_also📖GBA Glucocerebrosidase Dysfunction and Parkinson's Dise45%
see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 45%
see_also📖RAN Translation in Neurodegeneration45%
see_also📖Speech and Cognitive Biomarkers for Alzheimer's Disease45%
see_also📖Vagus Nerve Pathway in Neurodegeneration45%
see_also📖Hereditary Sensory and Autonomic Neuropathy (HSAN)45%
see_also📖MSA Clinical Features and Diagnosis45%
see_also📖Paranodal Dysfunction in Neurodegeneration45%
see_also📖Gait Analysis Parameter and Upper Limb Evaluation in Neurolo45%
see_also📖Pesticides and Parkinson Disease (Pest-PD) — NCT0642031045%
see_also📖PCDH19-Related Epilepsy (EFMR) — Preclinical Gene Therapy Pr45%
see_also📖Physical and Occupational Therapy in Corticobasal Syndrome45%
see_also📖TBK1 Autophagy and Neuroinflammation ALS/FTD Causal Chain45%
see_also📖Lipid Metabolism Dysregulation in Neurodegeneration45%
see_also📖Autosis Pathway in Neurodegeneration45%
see_also📖R-Loop Stress in Neurodegeneration45%
see_also📖Alpha-Synuclein Seeding Assays (RT-QuIC and PMCA)45%
see_also📖alexander-disease45%
see_also📖Glycosylation in Neurodegeneration45%
see_also📖Clinical Phenotypes and Subtypes of Corticobasal Syndrome45%
see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 45%
see_also📖Multi-Analyte Biomarker Panel for Parkinson's Disease D45%
see_also📖Nutritional Support and Dietary Interventions in Corticobasa45%
see_also📖RNA-Targeted Therapies in Neurodegeneration45%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)45%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration45%
see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration45%
see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration45%
see_also📖A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-C45%
see_also📖Natural History and Prognosis of Corticobasal Syndrome45%
see_also📖Down Syndrome Neurodegeneration Pathway45%
see_also📖FA2H-Associated Neurodegeneration Pathway45%
see_also📖Tertiary Lymphoid Organs in Neurodegeneration45%
see_also📖Japan Neurodegeneration Epidemiology45%
see_also📖CBS/PSP Panxoneopathy and Membrane Biology45%
see_also📖A Multicenter, Phase III, Randomized, Double Blind, Placebo-45%
see_also📖PSP Liquid-Liquid Phase Separation and Biomolecular Condensa45%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration45%
see_also📖CSF and Blood Biomarkers in Progressive Supranuclear Palsy45%
see_also📖A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial45%
see_also📖Histone Modification Pathways in Neurodegeneration45%
see_also📖MicroRNA Dysfunction in Neurodegeneration45%
see_also📖Liquid Biopsy in Neurodegeneration45%
see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener45%
see_also📖BLAAC PD - Black and African Americans Connections to PD (NC45%
see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration45%
see_also📖Caregiver Support and Palliative Care in Atypical [Parkinson45%
see_also📖Amylin Signaling in Neurodegeneration45%
see_also📖Speech and Language Deficits in Corticobasal Syndrome45%
see_also📖Shared Mechanisms Between Alzheimer and Parkinson Disease45%
see_also📖C9orf72 Repeat Expansions in CBS and PSP45%
see_also📖Global Neurodegeneration Epidemiology45%
see_also📖Endosomal Sorting Defects in Neurodegeneration45%
see_also📖COVID-19 Neurodegeneration Mechanism45%
see_also📖Geniposide for Alzheimer's disease - immune biomarker t45%
see_also📖Serotonergic Dysfunction in Neurodegeneration45%
see_also📖Protein Aggregation Seeds in Neurodegeneration45%
see_also📖Microglial Priming Pathway in Neurodegeneration45%
see_also📖NLRP3 Inhibitors in Parkinson's Disease: Research and C45%
see_also📖T-Cell Dysfunction in Neurodegeneration45%
see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration45%
see_also📖Familial vs Sporadic Neurodegeneration Comparison45%
see_also📖Cognitive and Speech Rehabilitation in CBS (NCT05823421)45%
see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration45%
see_also📖Sigma-1 Receptor Signaling in Neurodegeneration45%
see_also📖Neural Circuits in Neurodegeneration45%
see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain45%
see_also📖Sex Differences in Neurodegeneration45%
see_also📖PSP and Idiopathic Normal Pressure Hydrocephalus: Clinical O45%
see_also📖Prion Diseases in Neurodegeneration45%
see_also📖ALS Biomarkers and Disease Monitoring45%
see_also📖Computational Disease Models for Neurodegeneration45%
see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat45%
see_also📖Gait and Balance Disorders in Progressive Supranuclear Palsy45%
see_also📖SUMOylation in Neurodegeneration45%
see_also📖Social Behaviors and Quality of Life in Parkinson's Dis45%
see_also📖Mirror Therapy and Sensory Re-education in Corticobasal Synd45%
see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration45%
see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio45%
see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration45%
see_also📖Mitochondrial Fusion in Neurodegeneration45%
see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St45%
see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread45%
see_also📖Gait and Upper Limb Evaluation in PSP (NCT07136844)45%
see_also📖Braak Staging and Tau Propagation Pathway45%
see_also📖A 6-month & 18-month Prospective, Randomized, Placebo-co45%
see_also📖Ribosome Dysfunction in Neurodegeneration45%
see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen45%
see_also📖Pseudobulbar Affect and Emotional Lability in Corticobasal S45%
see_also📖Blood-Brain Barrier and Neuroimmune Interface in CBS/PSP45%
see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration45%
see_also📖Galectin-3 Mechanism in Neurodegeneration45%
see_also📖Synaptic Loss and Dysfunction Pathway45%
see_also📖Nitric Oxide Signaling in Neurodegeneration45%
see_also📖Neuropil Threads in Neurodegeneration45%
see_also📖Integrated Stress Response in Neurodegeneration45%
see_also📖India Neurodegeneration Epidemiology45%
see_also📖Neurovascular Unit Dysfunction in Neurodegeneration45%
see_also📖Neuroimaging Biomarkers for Neurodegeneration45%
see_also📖PKR Pathway in Neurodegeneration45%
see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration45%
see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)45%
see_also📖Vocational Rehabilitation and Driving in Corticobasal Syndro45%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)45%
see_also📖PSP Tau Propagation and Spreading Mechanisms45%
see_also📖NRF2 Signaling Pathway in Neurodegeneration45%
see_also📖CARASIL (Cerebral Autosomal Recessive Arteriopathy with Subc45%
see_also📖Disease Progression & Staging in Neurodegeneration45%
see_also📖Blood-Brain Barrier Dysfunction and Therapeutic Delivery for45%
see_also📖FTLD-TDP Subtypes and Mechanisms45%
see_also📖APOE4 and Alzheimer's Disease Risk45%
see_also📖Neuroinflammation in Parkinson's Disease Dementia and D45%
see_also📖Advanced Glycation End Products in Neurodegeneration45%
see_also📖PPAR Signaling Pathway in Neurodegeneration45%
see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration45%
see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati45%
see_also📖Protein Aggregation Comparison in Neurodegeneration45%
see_also📖Economic Burden — Neurodegeneration45%
see_also📖Investment Landscape: Parkinson's Disease45%
see_also📖IGF-1 Signaling Pathway in Neurodegeneration45%
see_also📖PI-2620 Tau PET Phase 3 (NCT05456503) - FTLD and Atypical AD45%
see_also📖Myoclonus and Cortical Hyperexcitability in Corticobasal Syn45%
see_also📖Cortical Involvement and Neurodegeneration in Progressive Su45%
see_also📖Caregiver Burden and Support in Corticobasal Syndrome45%
see_also📖Digital Therapeutic Platform for Swallowing and Drooling Pro45%
see_also📖NPTX1 and NPTXR CSF Markers Predict Alzheimer's Disease45%
see_also📖Pupillometry and Chromatic Pupillometry in Corticobasal Synd45%
see_also📖Investment Landscape: Frontotemporal Dementia45%
see_also📖Clinical Efficacy and Mechanism of tDCS for Dysphagia in Par45%
see_also📖Prion-Like Spread in Neurodegeneration45%
see_also📖Sleep and Circadian Dysfunction in Alzheimer's Disease45%
see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl45%
see_also📖IL-1 Signaling Pathway in Neurodegeneration45%
see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration45%
see_also📖Prion Protein Metabolism in Neurodegeneration45%
see_also📖Kidney-Brain Neurodegeneration Axis45%
see_also📖Polygenic Risk Score Integration Panel for Alzheimer's 45%
see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration45%
see_also📖Utilisation of Health Services and Quality of Life in Atypic45%
see_also📖Copper Homeostasis in Neurodegeneration45%
see_also📖Dysphagia and Nutritional Management in Corticobasal Syndrom45%
see_also📖GDF15/GDF11 Signaling in Neurodegeneration45%
see_also📖VEGF and Angiogenesis Dysregulation in CBS/PSP45%
see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio45%
see_also📖Glial Tau Pathology in PSP and CBD45%
see_also📖Exosomal Biomarkers in Neurodegeneration45%
see_also📖Sleep Disorders in Neurodegeneration45%
see_also📖Gangliosides in Neurodegeneration45%
see_also📖Retinal Degeneration Pathway in Neurodegeneration45%
see_also📖Neuronal Hyperexcitability in Neurodegeneration45%
see_also📖PSP Lysosomal Dysfunction and Autophagy Impairment45%
see_also📖Axon Guidance Pathways in Neurodegeneration45%
see_also📖Endothelin Signaling Pathway in Neurodegeneration45%
see_also📖Neuropeptide Y Signaling in Neurodegeneration45%
see_also📖Sandhoff Disease45%
see_also📖Hemiballismus and Hemichorea in Corticobasal Syndrome45%
see_also📖Investment Landscape: Huntington's Disease45%
see_also📖Advanced Proteolysis and Ubiquitin System Targeting in CBS/P45%
see_also📖Homocysteine Neurotoxicity and Neurodegeneration45%
see_also📖Purinergic Signaling in Neurodegeneration45%
see_also📖Cognitive Reserve and Resilience in Neurodegeneration45%
see_also📖MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acid45%
see_also📖Pupillary and Visual Dysfunction in Progressive Supranuclear45%
see_also📖Environmental Toxins and Parkinson's Risk45%
see_also📖Ghrelin Signaling Pathway in Neurodegeneration45%
see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime45%
see_also📖Japanese and German Case Series in Corticobasal Degeneration45%
see_also📖Digital Phenotyping in Neurodegeneration45%
see_also📖LRRK2 Gene Variants and Mutations45%
see_also📖Postural Dysfunction and Abnormalities in Corticobasal Syndr45%
see_also📖Antibody Therapy in Neurodegeneration45%
see_also📖Whole-Body Photobiomodulation for Motor and Cognitive Change45%
see_also📖LRRK2 Kinase Activation and Endolysosomal Dysfunction in Par45%
see_also📖ALS Therapeutic Landscape — Programs by Phase and Modality45%
see_also📖epigenetics-neurodegeneration45%
see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a45%
see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr45%
see_also📖Cross-National Cancer-Dementia Correlation and Shared Diseas45%
see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration45%
see_also📖Clostridium Butyricum for Motor and Non-motor Symptoms in Pa45%
see_also📖Prognostic Biomarkers in Neurodegeneration45%
see_also📖Voice and Speech in Corticobasal Syndrome45%
see_also📖Manganese-Related Neurodegeneration (Manganism)45%
see_also📖Therapeutic Targets in Neurodegeneration45%
see_also📖Iron and Neuromelanin Accumulation in PSP45%
see_also📖A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, M45%
see_also📖Cell-Free DNA Biomarkers in Neurodegeneration45%
see_also📖Quality of Life and Caregiver Burden in PSP (NCT03638505)45%
see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration45%
see_also📖Tau Seeding and Propagation Pathway45%
see_also📖AAIC 2026: Tau-PET Imaging and Fluid Biomarker Integration45%
see_also📖Sleep Architecture Changes in CBS and PSP45%
see_also📖PLA2G6-Associated Neurodegeneration (PLAN)45%
see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N45%
see_also📖mTOR Signaling in Autophagy and Lysosomal Function45%
see_also📖Endocannabinoid System in Neurodegeneration45%
see_also📖Alpha-Synuclein PET Imaging and Biomarker Advances45%
see_also📖p-Tau Biomarker in Immunoglobulin Light Chain and Transthyre45%
see_also📖Cancer-Dementia Inverse Correlation: Epidemiological Evidenc45%
see_also📖PSP Weight Loss and Cachexia45%
see_also📖P-Body (Processing Body) Pathway in Neurodegeneration45%
see_also📖Orexin Signaling in Neurodegeneration45%
see_also📖Neural Circuit Disruption in Neurodegeneration45%
see_also📖HMGB1 Signaling in Neurodegeneration45%
see_also📖Parthanatos in Neurodegeneration45%
see_also📖Sialorrhea and Drooling in Corticobasal Syndrome45%
see_also📖Speech and Voice Disorders in PSP45%
see_also📖Glymphatic and Vascular Clearance Dysfunction in 4R-Tauopath45%
see_also📖Senescent Cell Clearance in Neurodegeneration45%
see_also📖HLA Haplotypes and Neuroinflammatory Profiles in PSP45%
see_also📖US Neurodegeneration Epidemiology45%
see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)45%
see_also📖Metabolic Dysfunction and Insulin Resistance in Progressive 45%
see_also📖Multimodal Diagnostic Algorithm for CBS and PSP45%
see_also📖Diffusion MRI (DTI) in Neurodegeneration45%
see_also📖CNversyt and Megan Rodden ALS Trials45%
see_also📖Systemic Infection and Tau Pathology Acceleration45%
see_also📖Metal Homeostasis Dysregulation in Neurodegeneration45%
see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and45%
see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration45%
see_also📖Long-term Effects of Hearing Intervention on Brain Health in45%
see_also📖Synaptic Therapy Alzheimer's Research Trial (START): A 45%
see_also📖Pericyte Loss in Neurodegeneration45%
see_also📖interleukin-6-signaling-neurodegeneration45%
see_also📖Hippocampal Neurogenesis in Neurodegeneration45%
see_also📖Dystrophic Neurites in Neurodegeneration45%
see_also📖China Neurodegeneration Epidemiology45%
see_also📖Neurotensin Signaling in Neurodegeneration45%
see_also📖Quality of Life and Caregiver Burden in Progressive Supranuc45%
see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 45%
see_also📖NF-kB Signaling Pathway in Neurodegeneration45%
see_also📖S100 Protein Signaling Pathway in Neurodegeneration45%
see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration45%
see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration45%
see_also📖A Phase 3, Randomized, Double-blind, Placebo-controlled, Par45%
see_also📖mitochondrial-dysfunction-neurodegeneration-comparison45%
see_also📖European Neurodegeneration Epidemiology45%
see_also📖Paraptosis in Neurodegeneration45%
see_also📖Metabolomic Biomarkers in Neurodegeneration45%
see_also📖Somatic Mutations and Brain Mosaicism45%
see_also📖Cholinergic System Dysfunction in Neurodegeneration45%
see_also📖CaMKII Signaling Pathway in Neurodegeneration45%
see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration45%
see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration45%
see_also📖Exosomal miR-155 in Neurodegeneration45%
see_also📖Glymphatic Clearance Hypothesis — Impaired Aβ and Tau Remova45%
see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration45%
see_also📖A Phase III, Randomized, Double-Blind, Placebo-Controlled, M45%
see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration45%
see_also📖Convergent Pathways in Neurodegeneration45%
see_also📖RNA Splicing in Neurodegeneration45%
related🧪Senescent Cell Mitochondrial DNA Release40%
related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem40%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
related🧪Synthetic Biology BBB Endothelial Cell Reprogramming40%
related🧪Blood-Brain Barrier SPM Shuttle System40%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
related🧪Enteric Nervous System Prion-Like Propagation Blockade40%
related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener40%
related🧪Glymphatic System-Enhanced Antibody Clearance Reversal40%
related🔬What are the mechanisms underlying selective vulnerability o30%

💬 Discussion